Osteosarcoma Institute is located in Dallas, TX. The organization was established in 2018. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. As of 12/2021, Osteosarcoma Institute employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Osteosarcoma Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Osteosarcoma Institute generated $292.5k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (57.9%) each year. All expenses for the organization totaled $1.8m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Osteosarcoma Institute has awarded 17 individual grants totaling $2,771,129. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE OSTEOSARCOMA INSTITUTE WILL DEVELOP AND EXECUTE A COMPREHENSIVE, RATIONAL STRATEGY TO DRAMATICALLY IMPROVE THE LIFE EXPECTANCY OF RELAPSED AND METASTATIC OSTEOSARCOMA PATIENTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND TWO GRANTS FOR A TOTAL OF $1,300,000 FOR A CLINICAL TRIAL AND CORRELATIVE STUDY WITH THE DANA FARBER CANCER INSTITUTE. $225,473 OF THIS WAS FUNDED IN 2021.
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND GRANTS FOR A TOTAL OF $700,000 FOR CLINICAL TRIAL AND TRANSLATIONAL SCIENCE GRANT AGREEMENTS WITH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER. $250,000 OF THIS WAS FUNDED IN 2021.
THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A $500,000 PRECLINICAL AND TRANSLATIONAL SCIENCE GRANT AGREEMENT WITH CASE WESTERN RESERVE UNIVERSITY. THE BALANCE OF REMAINING OF $250,000 WAS FUNDED IN 2021.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Lee Helman Strategic Advisory Board | Officer | 16 | $204,595 |
Richard Gorlick Strategic Advisory Board | Trustee | 2 | $6,500 |
William Tap Strategic Advisory Board | Trustee | 2 | $6,500 |
Katherine Janeway Strategic Advisory Board | Trustee | 2 | $5,500 |
Fernanda Arnaldez Strategic Advisory Board | Trustee | 2 | $4,000 |
Andrea Hayes Dixon Strategic Advisory Board | Trustee | 2 | $4,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $291,789 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $291,789 |
Total Program Service Revenue | $0 |
Investment income | $712 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $292,501 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,223,573 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $214,298 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $71,865 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $4,742 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $12,882 |
Fees for services: Accounting | $8,115 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $57,500 |
Advertising and promotion | $193,394 |
Office expenses | $24,804 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $9,500 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $3,639 |
All other expenses | $0 |
Total functional expenses | $1,824,312 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $228,387 |
Savings and temporary cash investments | $1,826,504 |
Pledges and grants receivable | $4,690,880 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $6,745,771 |
Accounts payable and accrued expenses | $15,500 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $15,500 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $6,730,271 |
Total liabilities and net assets/fund balances | $6,745,771 |
Over the last fiscal year, Osteosarcoma Institute has awarded $1,221,473 in support to 7 organizations.
Grant Recipient | Amount |
---|---|
Columbus, OH PURPOSE: TRANSLATIONAL | $250,000 |
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: TRANSLATIONAL | $250,000 |
Cleveland, OH PURPOSE: TRANSLATIONAL | $250,000 |
Boston, MA PURPOSE: CLINICAL TRIAL | $225,473 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: CLINICAL TRIAL | $126,000 |
Farmington, MN PURPOSE: TRANSLATIONAL | $100,000 |
Over the last fiscal year, we have identified 3 grants that Osteosarcoma Institute has recieved totaling $61,350.
Awarding Organization | Amount |
---|---|
Rally Foundation Inc Atlanta, GA PURPOSE: PEDIATRIC CANCER STUDY | $25,000 |
Lizzys Walk Of Faith Columbia, MO PURPOSE: DONATION | $25,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $11,350 |
Organization Name | Assets | Revenue |
---|---|---|
Metis Foundation San Antonio, TX | $2,545,676 | $9,772,629 |
Dallas Va Research Corporation Dallas, TX | $3,000,158 | $2,339,367 |
Osteosarcoma Institute Dallas, TX | $6,745,771 | $292,501 |
International Safety Center Inc League City, TX | $6,098 | $197,232 |
Carnot Research Foundation Dallas, TX | $3,343 | $141,414 |
Childrens Optimal Health Austin, TX | $0 | -$123,152 |
Lifeplus Foundation Batesville, AR | $96,872 | $65,781 |
Thomas-Mcmahan Cancer Foundation New Orleans, LA | $161,954 | $54,510 |
International Veterinary Point-Of-Care Ultrasound Society Spicewood, TX | $56,671 | $0 |
Foundation Of Collaborative Unique Science Focus San Antonio, TX | $373,989 | $0 |
Center For Health And Economics Houston, TX | $0 | $0 |